Market Overview

Sotera Health's Nelson Labs Announces Acquisition of New Jersey-Based Gibraltar Laboratories

Share:

Acquisition strengthens Nelson Labs' outsourced testing
capabilities to better serve the pharmaceutical and medical device
industries

Sotera Health, the world's leading, fully integrated protector of global
health, announced today that it has acquired New Jersey-based Gibraltar
Laboratories. This acquisition expands the U.S.-based analytical testing
capabilities of Sotera Health's Nelson Labs business. Gibraltar
Laboratories is a leading outsourced provider of microbiology and
analytical chemistry testing for pharmaceutical and medical device
manufacturers. Terms of the deal were not disclosed.

Headquartered in Fairfield, New Jersey, Gibraltar Laboratories has an
outstanding reputation for customer service, technical expertise and
quality performance. Gibraltar is known for USP compendial microbiology,
sterility assurance and analytical chemistry testing. The company, owned
and operated by the Prince family since 1970, runs two laboratories in
the New Jersey tri-state area.

"Gibraltar Laboratories is a well-respected laboratory known for its
strong customer relationships with U.S.-based pharmaceutical
manufacturers," said Michael B. Petras Jr., CEO of Sotera Health. "In
addition to its testing expertise, Gibraltar's facilities are located in
the Northeast pharmaceutical corridor, home to many of the top
pharmaceutical manufacturers in the United States. This acquisition will
expand our presence in this important region and further strengthen our
testing capabilities for the pharmaceutical industry. We welcome
Gibraltar's strong management and expert staff as they join our mission
of Safeguarding Global HealthTM."

"Through the commitment of three generations of the Prince family, as
well as our experienced staff of microbiology and chemistry
professionals, we have earned a reputation as a reliable, responsive and
highly professional partner for our customers, and we know we have found
the same in Sotera Health," said Dr. Daniel L. Prince, President of
Gibraltar Laboratories. "My goal is for Gibraltar to continue to build
on its long-standing reputation of excellence and continue to expand its
offerings. We accomplish this by becoming part of Sotera Health, a
global company whose breadth of services and expansive reach provide
extraordinary value to the industries we are proud to serve."

"Gibraltar's offerings and the strategic location of its facilities will
be a great benefit to our mutual customers, who value working with a
trusted partner that can consistently deliver quality, service and
expertise," said Jeff Nelson, President of Nelson Labs. "The Gibraltar
team is known for these values and also has an excellent reputation for
designing specialized studies that help manufacturers prove the safety,
efficacy and regulatory compliance of their products. I am also
personally excited to be working directly with Dr. Daniel Prince, who I
consider a leading thinker in our field."

Gibraltar will complement Sotera Health's Nelson Labs business.
Gibraltar's expertise in pharmaceutical products and analytical testing
capabilities will enhance Nelson Labs' existing strengths in medical
device microbiology and expert advisory services. Gibraltar's facilities
are FDA registered and ISO 17025 accredited and have the distinction of
being accredited for both the microbiological and chemical fields. The
acquisition of Gibraltar Laboratories does not include Prince
Sterilization Services, LLC. However, both companies are excited that
Gibraltar will continue to maintain a partnership with Prince
Sterilization Services to provide the testing needed to certify their
products.

About Sotera Health: Sotera
Health LLC, along with its business entities,
is
the world's leading, fully integrated protector of global health. With
over 500 years of combined scientific expertise, the company ensures the
safety of healthcare by providing mission-critical services to the
medical device, pharmaceutical, tissue and food industries. Sotera
Health operates 63 facilities in 13 countries. The company has over
2,600 employees globally and touches the lives of more than 180 million
people around the world each year. Sotera Health serves more than 5,000
customers worldwide, including 75 of the top 100 medical device
manufacturers.

Sotera Health goes to market through its three best-in-class companies – Nelson
Labs™
, Nordion®
and Sterigenics®
– with the mission of ensuring the safety of health care each and every
day. Nelson Labs offers microbiological and analytical testing and
expert advisory services to assist customers in developing and
maintaining sterilization solutions in medical devices,
tissue/implantable products, and the pharmaceutical and biologics
fields. Nordion is the world's largest provider of Cobalt-60 used in the
gamma sterilization process, and Sterigenics provides comprehensive
contract sterilization and ionization solutions for the medical device,
pharmaceutical, food safety and high-performance materials industries.

Sotera Health LLC is owned by private equity firms Warburg Pincus and
GTCR. Learn more about Sotera Health at soterahealth.com,
about Nelson Labs at nelsonlabs.com,
about Nordion at nordion.com
and about Sterigenics at sterigenics.com.

About Nelson Laboratories: Nelson Laboratories, LLC is the
industry-leading provider of global lab testing and expert advisory
services. Nelson Labs performs over 400 rigorous microbiological and
analytical laboratory tests, including a best-in-class extractables and
leachables testing platform, for the medical device, pharmaceutical and
tissue industries. The company is regarded as a best-in-class partner
with a strong track record of collaborating with customers to solve
complex issues. With 11 global laboratory locations in 8 countries,
Nelson Labs is committed to Safeguarding Global HealthTM with
every test they complete.

About Gibraltar Laboratories: With an outstanding reputation for
customer service, quality research, quality control and testing in stem
cells, bacteriology, mycology, virology, chemistry, cleaning validations
and in vitro toxicology, Gibraltar Laboratories has set the Gold
Standard for contract laboratories. Gibraltar Laboratories proudly
serves the pharmaceutical, medical device, orthopedic, tissue bank,
biopharmaceutical, chemical, and cosmetic industries. The company
operates two laboratories and is based in Fairfield, New Jersey. To
learn more, visit www.gibraltarlabsinc.com.

View Comments and Join the Discussion!